Aspiring participants of the GATE 2025 Biotechnology (BT) exam must go through the syllabus of Biotechnology (BT). The ...

Touchlight, a pioneering leader in synthetic DNA technology, is pleased to announce the appointment of Will Downie as a key adviser to support its mission in advancing genetic medicines. Downie’s ...

Maravai LifeSciences, Inc. , a global provider of life science reagents and services to researchers and biotech innovators, announced today its acquisition of intellectual property and relevant assets ...

Financial writer discusses MGX's gene editing technology, cash runway, and lack of clinical data for potential future ...

Scientists have unveiled a groundbreaking method to test how thousands of active substances influence cellular metabolism ...

Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) have been given an average rating of ...

Researchers at the University of Basel are able to test in parallel the effects of over 1,500 active substances on cell metabolism. Their analysis also led to the discovery of previously unknown ...

STOCKHOLM, Jan. 28, 2025 /PRNewswire/ -- EQT is pleased to announce that EQT Life Sciences has led a USD 75 million Series B funding round in Atalanta Therapeutics ("Atalanta" or "the Company").

Appoints Simon Harnest as Chief Financial Officer to advance capital markets and corporate development strategy supporting TOS-358, the Company’s lead covalent PI3Kα inhibitor, and additional ...

The early stage company is developing a new approach to gene editing to treat rare genetic diseases. It does this using mRNA, ...

Ancient DNA studies provide critical insights into human evolution and extinct species, leveraging advanced techniques to ...

Strong government Investments and Precision medicine Propel Growth in Sanger Sequencing Market, Expected to Quadruple Its Size Over the Next Decade ...